Wallace DJ, Ginzler EM, Merrill JT, et al. Sustained safety and efficacy over 10 years with belimumab (BEL) plus standard systemic lupus erythematosus (SLE) therapy (SOC) in patients with SLE. EULAR 2017, #OP0232.
Riociguat bij vroege diffuus cutane systemische sclerose: RISE-SSc
jan 2024 | ILD, Sclerodermie